Novel imaging model helps reveal new therapeutic target for pancreatic cancer

Pancreatic ductal adenocarcinoma, the most common of pancreatic cancers, is extraordinarily lethal, with a five-year survival rate of just 6 percent. In a new study, researchers describe an innovative new model that not only allowed them to track drug resistance in vivo, but also revealed a new therapeutic target.